entertainment -WSS

entertainment

author：hotspot 2025-09-29 01:38:40 - browse：9856

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Akili, maker of video game for ADHD, to be acquired for 34 million

focus

WSS

Heat waves linked to early deliveries, preterm births in new study

The biotech scorecard for Q3: 15 stock

Being 'nonadherent' patient made me a more empathetic doctor

David Sabatini, ex

Fatty liver disease was alleviated by Lilly’s ‘triple

Prescription digital therapeutics are key to pharma’s future

entertainment

entertainment

explore

Walensky prepares to leave CDC — and Congress — behind

Canadians with cystic fibrosis outlive Americans by a decade

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biohaven protein

Guidelines to prevent youth baseball injuries need more muscle

STAT wants to know your pick for a great summer read or listen

In age of alternative facts, a scholarly course on calling out crap

Security flaws in third

What does generative AI mean for health care? We asked experts

Insmed lung disease drug hits target in key Phase 3 trial

leisure time

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Canadians with cystic fibrosis outlive Americans by a decade

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

The wait for US passports is creating travel purgatory and snarling summer plans

Undocumented workers face uncertainty as immigration law takes effect in Florida

focus

focus

focus

entertainment